2021
DOI: 10.21215/kjfp.2021.11.4.236
|View full text |Cite
|
Sign up to set email alerts
|

Updates on Coronavirus Disease 19 Vaccine and Its Clinical Application

Abstract: The global epidemic of COVID-19 (coronavirus disease 2019), which began at the end of 2019, is currently in progress, and the largest number of confirmed cases in the Republic of Korea has been renewed day after day as of July 2021 due to COVID-19 virus variants. Vaccines have effectively suppressed many infectious diseases in human history, and the introduction and dissemination of vaccines are also essential for prevention and reduction of severity and death in COVID-19. This paper provides scientific inform… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…In Israel, the analysis of approximately 4,710,000 persons who received 2 doses of the Pfizer vaccine showed a 97.2% (95% CI, 96.8%–97.5%) effectiveness in the prevention of hospital admission and a 96.7% (95% CI, 96.0%–97.3%) effectiveness in the prevention of death [ 5 ]. In a previous US study, the prevention effectiveness of 2 doses of the Pfizer or Moderna vaccines was 90% in healthcare professionals, and the prevention of hospital admission in persons aged ≥65 years was 94% (95% CI, 49%–99%) [ 6 ]. In the UK, the COVID-19 prevention effectiveness of 2 doses of the Pfizer vaccine among healthcare professionals was 85% (95% CI, 74%–96%) [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…In Israel, the analysis of approximately 4,710,000 persons who received 2 doses of the Pfizer vaccine showed a 97.2% (95% CI, 96.8%–97.5%) effectiveness in the prevention of hospital admission and a 96.7% (95% CI, 96.0%–97.3%) effectiveness in the prevention of death [ 5 ]. In a previous US study, the prevention effectiveness of 2 doses of the Pfizer or Moderna vaccines was 90% in healthcare professionals, and the prevention of hospital admission in persons aged ≥65 years was 94% (95% CI, 49%–99%) [ 6 ]. In the UK, the COVID-19 prevention effectiveness of 2 doses of the Pfizer vaccine among healthcare professionals was 85% (95% CI, 74%–96%) [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…In particular, breakthrough infection was derived from topic 4 of LAD topic modeling and cluster 2 of CONCOR analysis, where the breakthrough infection was defined as a confirmed COVID-19 case after 14 days from the day of completing vaccination ( 31 ). These results are thought to be because the currently prevalent Omicron variant spreads quickly due to its high contagious power and the immunity gained from vaccination or previous COVID-19 infection is less effective due to its immune evasion ability.…”
Section: Discussionmentioning
confidence: 99%
“…Individuals in this group do not develop secondary infections. The vaccine’s efficacy against the mutant is slightly inferior than that against the original virus [ 35 38 ]. …”
Section: Methodsmentioning
confidence: 99%
“…6. The vaccine's efficacy against the mutant is slightly inferior than that against the original virus [35][36][37][38].…”
mentioning
confidence: 99%